DCI Partners: A venture capital firm in Japan and Taiwan, specializing in biotech start-ups in regenerative medicine.
Location
Tokyo, JP
Founded
2014
DCI Partners is a venture capital firm specializing in biotech start-ups within the therapeutic field, particularly focusing on regenerative medicine. The firm operates primarily in Japan and Taiwan, targeting companies that are in the Series B investment stage.
Notable portfolio companies include Aprinoia Therapeutics, which has raised $11.1 million. DCI Partners is known for its deep expertise in the biotech sector and offers significant value-add services to its portfolio companies, leveraging its extensive network and industry knowledge to support growth and innovation.
DCI Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series B1 (100.0%)
Stage Mix
Series B 100%
Concentration shown as share of disclosed investments by stage.